Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For AVVIY
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q2 Q4 Δ in %
Current Ratio -77.66 0.28 1.25
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -92.94 9.37 -132.75
Naive Interpretation member
2 Per Share
Metric Q2 Q4 Δ in %
Book Value -4.93 3.23 3.40
Cash 44.92 10.39 7.17
Capex -363.89 -0.11 -0.02
Free Cash Flow -46.73 -0.71 -0.49
Revenue 39.91 7.40 5.29
Naive Interpretation member
3 Profitability
Metric Q2 Q4 Δ in %
Gross Margin 0.00 1.00 1.00
Operating Margin 338.51 0.11 0.02
ROA 99.95 < 0.005 < 0.005
ROE 115.45 0.08 0.04
ROIC 370.65 0.08 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of AVVIY is permitted for members.
5 Growth
The "Growth Entry" for the Focus of AVVIY is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of AVVIY is permitted for members.